L‐Deprenylnitric oxide production and dilation of cerebral blood vessels
作者:
Tom Thomas,
Chris McLendon,
George Thomas,
期刊:
NeuroReport
(OVID Available online 1998)
卷期:
Volume 9,
issue 11
页码: 2595-2600
ISSN:0959-4965
年代: 1998
出版商: OVID
关键词: Alzheimer's disease;β-Amyloid;L-Deprenyl;Endothelium;Free radicals;Neuroprotection;Nitric oxide;Parkinson's disease
数据来源: OVID
摘要:
THE monoamine oxidase-B inhibitor L-deprenyl (Selegiline) is effective in treating Parkinson's disease and possibly Alzheimer's disease. The neuroprotective property of L-deprenyl may be unrelated to the inhibition of monoamine oxidase-B. Since nitric oxide (NO) modulates activities including cerebral blood flow and memory, we examined the effect of L-deprenyl on NO. L-Deprenyl induced rapid increases in NO production in brain tissue and cerebral vessels. Vasodilation was produced by endothelial NO-dependent as well as NO-independent mechanisms in cerebral vessels. The drug also protected the vascular endothelium from the toxic effects of amyloid-β peptide. These novel actions of selegiline may protect neurons from ischemic or oxidative damage and suggest new therapeutic applications for L-deprenyl in vascular and neurodegenerative diseases.
点击下载:
PDF
(213KB)
返 回